Eli Lilly recently announced exciting results from a mid-stage trial, showcasing the potential of its popular drug, tirzepatide, in treating fatty liver disease. This drug, widely known for its effectiveness in weight loss and diabetes management, demonstrated positive outcomes in a phase two study involving patients with metabolic dysfunction-associated steatohepatitis (MASH). The findings suggest that
0 Comments
The U.S. Department of Education recently unveiled a new initiative called the “FAFSA College Support Strategy” to address the numerous setbacks faced in the processing of Free Application for Federal Student Aid (FAFSA) forms. Secretary of Education Miguel Cardona expressed determination to rectify the situation, collaborating with high-need institutions and offering a concierge service to
0 Comments
Billionaire Adam Neumann, the co-founder of WeWork, is reportedly making efforts to buy back the bankrupt real-estate company, as reported by DealBook. Neumann, along with his startup Flow and Dan Loeb’s Third Point fund, has conveyed a “sincere interest” in acquiring WeWork and its leases either through bankruptcy proceedings or by providing debtor-in-possession (DIP) financing.
0 Comments
The realm of mortgage rates has been a rollercoaster ride, with the average rate on the popular 30-year fixed mortgage reaching 7.04%, a threshold unseen since December. This recent escalation comes hot on the heels of a substantial surge prompted by the unexpected boost in the January employment report. The plot thickened as a monthly
0 Comments